Related Experiment Video
Updated: May 16, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
MicroRNA-204-5p regulates epithelial-to-mesenchymal transition during human posterior capsule opacification by
Ye Wang1, Wenfeng Li, Xinjie Zang
1State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao, China.
Purpose:
To investigate the role of microRNA (miRNA) in regulating epithelial-to-mesenchymal transition (EMT) during human posterior capsule opacification (PCO).
Methods:
A miRCURY LNA microRNA array was used to evaluate the miRNA profiles of human PCO tissues and normal attached lens epithelial cells (LECs). An in vitro human donor capsular bag model was used to investigate the role of miRNAs in the EMT during PCO. The expression of SMAD4, phospho-SMAD2/3, and a panel of EMT markers was detected by Western blot and quantitative RT-PCR.
Results:
The results of miRNA profiling in human PCO tissues and normal attached LECs demonstrated that, among other miRNAs, miR-204-5p expression was down-regulated. Using bioinformatics, we identified SMAD4, one of the mediators of TGF-β/SMAD signaling, as a predicted target of miR-204-5p. Overexpression of miR-204-5p in primary LECs increased E-cadherin expression and decreased the expression of vimentin and alpha smooth muscle actin. Furthermore, miR-204-5p overexpression enhanced the repression of TGF-β2-induced EMT in the presence of SMAD4 small interfering RNA.
Conclusions:
Our data provide firm evidence of a role for miR-204-5p in the direct regulation of EMT through its targeting of SMAD4 and, consequently, TGF-β signaling. Because of its ability to repress the EMT, miR-204-5p may be a novel target for PCO therapeutic intervention.
Insights
MicroRNA-204-5p plays a key role in preventing posterior capsule opacification (PCO) by inhibiting epithelial-to-mesenchymal transition (EMT). This microRNA targets SMAD4, offering a potential therapeutic avenue for PCO treatment.
Area of Science:
- Ophthalmology
- Molecular Biology
- Cell Biology
Background:
- Posterior capsule opacification (PCO) is a common complication after cataract surgery.
- Epithelial-to-mesenchymal transition (EMT) of lens epithelial cells (LECs) is a key process in PCO development.
- MicroRNAs (miRNAs) are known regulators of cellular processes, including EMT.
Purpose of the Study:
- To investigate the role of specific miRNAs in regulating EMT during human PCO.
- To identify potential miRNA targets involved in the PCO pathway.
Main Methods:
- miRNA profiling of human PCO tissues and normal LECs using miRCURY LNA arrays.
- In vitro analysis using a human donor capsular bag model.
- Western blot and quantitative RT-PCR to assess expression of EMT markers and signaling proteins (SMAD4, phospho-SMAD2/3).
Main Results:
- miR-204-5p expression was significantly down-regulated in human PCO tissues.
- SMAD4 was identified as a direct target of miR-204-5p.
- Overexpression of miR-204-5p in LECs suppressed EMT markers (vimentin, alpha smooth muscle actin) and increased E-cadherin.
- miR-204-5p overexpression inhibited TGF-β2-induced EMT, particularly when SMAD4 was silenced.
Conclusions:
- miR-204-5p directly regulates EMT by targeting SMAD4 and influencing TGF-β signaling.
- miR-204-5p's ability to repress EMT suggests its potential as a therapeutic target for PCO.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
TGF - β Signaling Pathway
Role of Matrix Metalloproteases in Degradation of ECM
A...
